“Collectively, DS can augment the anti-angiogenic activity of Sild and PTX during HPS through regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways.”
“Furthermore, DS combination with Sild or PTX exhibited an improvement in HPS in comparison to each drug alone.”